Branched-Chain Amino Acids for Maple Syrup Disease Monitoring
Gaucher Disease
Galactokinase, Blood
Food poisoning
Testosterone, Total
Immunoglobulin E (IgE)
Citric Acid, Serum
Grave's disease
CACNA1A (calcium voltage-gated channel subunit alpha1 A) Gene Mutation Analysis
Alpha-L-Iduronidase (IDUA) Genetic Mutation Analysis
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
CPT
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now
Loading...